Research Keyword: prognosis

Prognostic model for gastric cancer patients with COVID-19 and network pharmacology study on treatment by lentinan

mycolabadmin

This study investigated how lentinan, a compound from shiitake mushrooms, might help treat patients who have both gastric cancer and COVID-19. Researchers identified five genes that predict patient outcomes and found that lentinan may work by controlling immune cell activity and reducing inflammation. The study suggests lentinan could be a useful additional treatment for this challenging combination of diseases, though more research is needed.

Read More »

Necrotizing orbital infections: A comprehensive review

mycolabadmin

Necrotizing orbital infections are serious, fast-spreading infections around the eye caused by bacteria, fungi, or viruses. These infections can cause vision loss and can be life-threatening, especially for people with weakened immune systems. Quick diagnosis and aggressive treatment with antibiotics or antifungal medications, combined with surgery to remove infected tissue, are essential to save sight and prevent death.

Read More »

Unveiling SSR4: a promising biomarker in esophageal squamous cell carcinoma

mycolabadmin

Researchers discovered that a protein called SSR4 is overexpressed in esophageal cancer cells and is associated with poor patient outcomes. This protein appears to be involved in how cancer cells communicate with immune cells in the tumor environment. The findings suggest SSR4 could be used as a diagnostic marker and potential therapeutic target for treating esophageal cancer patients.

Read More »
Scroll to Top